s6y

4 Kite Pharma, Inc.: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001209191-14-044192

Documents

  1. FORM 4 SUBMISSION 4
  2. POA DOCUMENT EX-24.4_529499

On sec.gov